Recall Register

Device recall: Etest Ceftaroline (CPT32) WW B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for…

Class III FDA enforcement event 69579. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

The products have a wrong expiration date on their labeling, 5 years instead of 2 years.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Biomerieux started this device recall on 16 Oct 2014. The firm address in the FDA record is in Letoile. FDA put the recall in Class III. FDA event 69579 has 5 product records. The first FDA enforcement report date is 26 Nov 2014. The record gives the status Terminated, with the termination date 30 Nov 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide Distribution-US (nationwide) including DC and the states of AL, AK, AR, AZ, CA, CO, DE, FL, GA, IA, IN, KY, MA, MD, MI, MO, NC, NE, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, and the…

Recalling firm

Biomerieux, Letoile, N/A, France.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

5 product records in the event.

FDA event 69579: product records
Recall numberProductQuantityClassStatusReport date
Z-0230-2015Etest Ceftaroline (CPT32) WW B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.652 devicesClass IIITerminated26 Nov 2014
Z-0231-2015Etest Ceftaroline (CPT32) WWB100. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.652 devicesClass IIITerminated26 Nov 2014
Z-0232-2015Etest Ceftaroline (CPT32) US B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.652 devicesClass IIITerminated26 Nov 2014
Z-0233-2015Etest Ceftaroline (CPT32) US B100. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.652 devicesClass IIITerminated26 Nov 2014
Z-0234-2015Etest Ceftaroline (CPT32) US B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.652 devicesClass IIITerminated26 Nov 2014

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Device events that started in 2014
1,176
Share of these events in Class III
4%
Product records in this event
5Median of the firm: 5
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of Biomerieux
InitiatedProduct (first record)TypeClassRecords
19 Nov 2015Etest Piperacillin/tazobactam (4 ug/mL) PTc0.016-256-pack of 30 tests WW Etest is a quantitative technique for determiniDeviceClass I4

Official channels

Cite this page

Recall Register. FDA enforcement event 69579. https://recallregister.com/fda/iii/69579/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide Distribution-US (nationwide) including DC and the states of AL, AK, AR, AZ, CA, CO, DE, FL, GA, IA, IN, KY, MA, MD, MI, MO, NC, NE, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, and the…
What quantity of product is in FDA event 69579?
The event has 5 product records. The first record gives this quantity: 652 devices
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2014 have the same class?
4% of the 1,176 device events that started in 2014 are in Class III.